Mega Genomics Limited (6667) Stock Statistics & Valuation Metrics

Mega Genomics Limited has a market cap or net worth of HK$1.61B. The enterprise value is HK$1.00B.

Mega Genomics Limited has 224,300,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mega Genomics Limited’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 2.21%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Mega Genomics Limited had revenue of 151.30M and earned 30.04M in profits. Earnings per share was 0.14.

In the last 12 months, operating cash flow was 111.33M and capital expenditures -23.80M, giving a free cash flow of 87.53M billion.

Mega Genomics Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Mega Genomics Limited upcoming earnings date is Aug 28, 2025, TBA (Confirmed).

Mega Genomics Limited as a current ratio of 5.84, with Debt / Equity ratio of 6.25%

In the past 12 months, Mega Genomics Limited has paid 6.14M in taxes.

Mega Genomics Limited EV to EBITDA ratio is 28.74, with an EV/FCF ratio of 11.81.

Mega Genomics Limited has HK$508.93M in cash and marketable securities with ¥41.42M in debt, giving a net cash position of -HK$467.51M billion.

Gross margin is 60.76%, with operating margin of 12.24%, and net profit margin of 19.85%.

The average price target for Mega Genomics Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―